Content oversight and quality assurance provided by Bay Area News Group.

Bay Area News Group advertising leadership oversees sponsored, native, and paid content on this platform, ensuring its quality, relevance, and helpfulness for our audience.

Articles attributed to this byline are authored by paying advertisers. The editorial team did not contribute to these pieces, and the opinions expressed do not necessarily represent those of the editorial staff. Refer to our partner statement to better understand the nature of the relationship.

The sponsor retains responsibility for the content and holds the copyright to their material.

For patients battling relapsed or treatment-resistant cancers, treatment options can feel limited, and the search for effective care can be overwhelming. At Epi

See Full Page